Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Biliary Tract Diseases

Free Subscription Articles published in PLoS One Retrieve available abstracts of 86 articles: HTML format Text format

Single Articles

January 2018
1. ZENOUZI R, von der Gablentz J, Heldmann M, Gottlich M, et al
   Patients with primary biliary cholangitis and fatigue present with depressive symptoms and selected cognitive deficits, but with normal attention performance and brain structure.
   PLoS One. 2018;13:e0190005.
   PubMed     Text format     Abstract available
   
   
   
2. IIDA T, Kaneto H, Wagatsuma K, Sasaki H, et al
   Efficacy and safety of endoscopic procedures for common bile duct stones in patients aged 85 years or older: A retrospective study.
   PLoS One. 2018;13:e0190665.
   PubMed     Text format     Abstract available
   
   
   
3. PERALDO-NEIA C, Cavalloni G, Fenocchio E, Cagnazzo C, et al
   Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.
   PLoS One. 2018;13:e0191593.
   PubMed     Text format     Abstract available
   
   
   
4. GOOKIN JL, Mathews KG, Cullen J, Seiler G, et al
   Qualitative metabolomics profiling of serum and bile from dogs with gallbladder mucocele formation.
   PLoS One. 2018;13:e0191076.
   PubMed     Text format     Abstract available
   
   
   
5. LEE HS, Chung MJ, Park JY, Bang S, et al
   Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis.
   PLoS One. 2018;13:e0190835.
   PubMed     Text format     Abstract available
   
   
   
6. NGUYEN HH, Shaheen AA, Baeza N, Lytvyak E, et al
   Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
   PLoS One. 2018;13:e0193960.
   PubMed     Text format     Abstract available
   
   
   
7. ANDRES A, Montano-Loza A, Greiner R, Uhlich M, et al
   A novel learning algorithm to predict individual survival after liver transplantation for primary sclerosing cholangitis.
   PLoS One. 2018;13:e0193523.
   PubMed     Text format     Abstract available
   
   
   
8. SHAHEEN AA, Kaplan GG, Almishri W, Vallerand I, et al
   The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
   PLoS One. 2018;13:e0194839.
   PubMed     Text format     Abstract available
   
   
   
9. BIAN S, Chen H, Wang L, Fei Y, et al
   Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.
   PLoS One. 2018;13:e0194397.
   PubMed     Text format     Abstract available
   
   
   
10. LIAO CY, Chung CH, Chu P, Wei KY, et al
    Increased risk of osteoporosis in patients with primary biliary cirrhosis.
    PLoS One. 2018;13:e0194418.
    PubMed     Text format     Abstract available
    
    
    
11. KELLER S, Aigner A, Zenouzi R, Kim AC, et al
    Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis.
    PLoS One. 2018;13:e0193929.
    PubMed     Text format     Abstract available
    
    
    
12. KANG J, Lee SH, Son JH, Lee JW, et al
    Body mass index and weight change during initial period of chemotherapy affect survival outcome in advanced biliary tract cancer patients.
    PLoS One. 2018;13:e0195118.
    PubMed     Text format     Abstract available
    
    
    
13. WIELDERS CLC, van Nierop P, Vormer TL, Foijer F, et al
    RNAi screening of subtracted transcriptomes reveals tumor suppression by taurine-activated GABAA receptors involved in volume regulation.
    PLoS One. 2018;13:e0196979.
    PubMed     Text format     Abstract available
    
    
    
14. LIU T, Wang W, Ji Y, Wang Y, et al
    Association between different combination of measures for obesity and new-onset gallstone disease.
    PLoS One. 2018;13:e0196457.
    PubMed     Text format     Abstract available
    
    
    
15. FRYBOVA B, Drabek J, Lochmannova J, Douda L, et al
    Cholelithiasis and choledocholithiasis in children; risk factors for development.
    PLoS One. 2018;13:e0196475.
    PubMed     Text format     Abstract available
    
    
    January 2017
16. ZEC S, Popovic D, Matovic V, Nikolic V, et al
    Translation and validation of the Serbian primary biliary cholangitis-40 questionnaire.
    PLoS One. 2017;12:e0175697.
    PubMed     Text format     Abstract available
    
    
    
17. HUSZAR O, Kokas B, Matrai P, Hegyi P, et al
    Meta-Analysis of the Long Term Success Rate of Different Interventions in Benign Biliary Strictures.
    PLoS One. 2017;12:e0169618.
    PubMed     Text format     Abstract available
    
    
    
18. REUKEN PA, Torres D, Baier M, Loffler B, et al
    Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis.
    PLoS One. 2017;12:e0169900.
    PubMed     Text format     Abstract available
    
    
    
19. UDOMSINPRASERT W, Kitkumthorn N, Mutirangura A, Chongsrisawat V, et al
    Association between Promoter Hypomethylation and Overexpression of Autotaxin with Outcome Parameters in Biliary Atresia.
    PLoS One. 2017;12:e0169306.
    PubMed     Text format     Abstract available
    
    
    
20. NELSON SM, Gao YT, Nogueira LM, Shen MC, et al
    Diet and biliary tract cancer risk in Shanghai, China.
    PLoS One. 2017;12:e0173935.
    PubMed     Text format     Abstract available
    
    
    
21. CHEN JH, Borges M
    Histopathology and enhanced detection of tumor invasion of peritoneal membranes.
    PLoS One. 2017;12:e0173833.
    PubMed     Text format     Abstract available
    
    
    
22. ZHANG BB, Yan C, Fang F, Du Y, et al
    Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis.
    PLoS One. 2017;12:e0171005.
    PubMed     Text format     Abstract available
    
    
    
23. DE LOMBAERDE S, Neyt S, Kersemans K, Verhoeven J, et al
    Synthesis, in vitro and in vivo evaluation of 3beta-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice.
    PLoS One. 2017;12:e0173529.
    PubMed     Text format     Abstract available
    
    
    
24. CHO S, Lee TS, Song IH, Kim AR, et al
    Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma.
    PLoS One. 2017;12:e0170078.
    PubMed     Text format     Abstract available
    
    
    
25. ESTIU MC, Frailuna MA, Otero C, Dericco M, et al
    Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid.
    PLoS One. 2017;12:e0176504.
    PubMed     Text format     Abstract available
    
    
    
26. KEMPINSKA-PODHORODECKA A, Milkiewicz M, Jablonski D, Milkiewicz P, et al
    ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis.
    PLoS One. 2017;12:e0176264.
    PubMed     Text format     Abstract available
    
    
    
27. YAGAI T, Matsui S, Harada K, Inagaki FF, et al
    Expression and localization of sterile alpha motif domain containing 5 is associated with cell type and malignancy of biliary tree.
    PLoS One. 2017;12:e0175355.
    PubMed     Text format     Abstract available
    
    
    
28. QU X, Sheng J, Shen L, Su J, et al
    Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS.
    PLoS One. 2017;12:e0173712.
    PubMed     Text format     Abstract available
    
    
    
29. RAO ZZ, Zhang XW, Ding YL, Yang MY, et al
    miR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: Role of PXR/MRP3.
    PLoS One. 2017;12:e0178702.
    PubMed     Text format     Abstract available
    
    
    
30. SHNEIDER BL, Moore J, Kerkar N, Magee JC, et al
    Initial assessment of the infant with neonatal cholestasis-Is this biliary atresia?
    PLoS One. 2017;12:e0176275.
    PubMed     Text format     Abstract available
    
    
    
31. IINO C, Shimoyama T, Igarashi T, Aihara T, et al
    Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer.
    PLoS One. 2017;12:e0178777.
    PubMed     Text format     Abstract available
    
    
    
32. GRANATA V, Fusco R, Catalano O, Avallone A, et al
    Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.
    PLoS One. 2017;12:e0179951.
    PubMed     Text format     Abstract available
    
    
    
33. LIN WC, Lin HH, Hung CY, Shih SC, et al
    Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding.
    PLoS One. 2017;12:e0177449.
    PubMed     Text format     Abstract available
    
    
    
34. WANG C, Yang Y, Sun D, Jiang Y, et al
    Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: A meta-analysis.
    PLoS One. 2017;12:e0176827.
    PubMed     Text format     Abstract available
    
    
    
35. KATO S, Chinen K, Shinoura S, Kikuchi K, et al
    Predictors for bile duct stone recurrence after endoscopic extraction for naive major duodenal papilla: A cohort study.
    PLoS One. 2017;12:e0180536.
    PubMed     Text format     Abstract available
    
    
    
36. LI Z, Lin B, Lin G, Wu Y, et al
    Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.
    PLoS One. 2017;12:e0178580.
    PubMed     Text format     Abstract available
    
    
    
37. PEREIRA P, Aho V, Arola J, Boyd S, et al
    Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.
    PLoS One. 2017;12:e0182924.
    PubMed     Text format     Abstract available
    
    
    
38. JEE J, Mourya R, Shivakumar P, Fei L, et al
    Cxcr2 signaling and the microbiome suppress inflammation, bile duct injury, and the phenotype of experimental biliary atresia.
    PLoS One. 2017;12:e0182089.
    PubMed     Text format     Abstract available
    
    
    
39. ADEYEMI O, Alvarez-Laviada A, Schultz F, Ibrahim E, et al
    Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis.
    PLoS One. 2017;12:e0183167.
    PubMed     Text format     Abstract available
    
    
    
40. WANG X, Wen X, Zhou J, Qi Y, et al
    MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients.
    PLoS One. 2017;12:e0184292.
    PubMed     Text format     Abstract available
    
    
    
41. FAGAGNINI S, Heinrich H, Rossel JB, Biedermann L, et al
    Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases.
    PLoS One. 2017;12:e0185193.
    PubMed     Text format     Abstract available
    
    
    
42. YE Y, Li Z, Feng Q, Chen Z, et al
    Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3.
    PLoS One. 2017;12:e0180896.
    PubMed     Text format     Abstract available
    
    
    
43. PETRICK JL, Yang B, Altekruse SF, Van Dyke AL, et al
    Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.
    PLoS One. 2017;12:e0186643.
    PubMed     Text format     Abstract available
    
    
    
44. LEE S, Kweon OK, Kim WH
    Associations between serum leptin levels, hyperlipidemia, and cholelithiasis in dogs.
    PLoS One. 2017;12:e0187315.
    PubMed     Text format     Abstract available
    
    
    
45. IGARASHI K, Yamashita K, Katoh H, Kojima K, et al
    Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
    PLoS One. 2017;12:e0188178.
    PubMed     Text format     Abstract available
    
    
    
46. PINHEIRO D, Leiros L, Dau JBT, Stumbo AC, et al
    Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice.
    PLoS One. 2017;12:e0187970.
    PubMed     Text format     Abstract available
    
    
    January 2016
47. SAKAMOTO T, Kobayashi S, Yamada D, Nagano H, et al
    A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer.
    PLoS One. 2016;11:e0145985.
    PubMed     Text format     Abstract available
    
    
    
48. LIN L, Guo L, Zhang W, Cai X, et al
    Novel Silicone-Coated 125I Seeds for the Treatment of Extrahepatic Cholangiocarcinoma.
    PLoS One. 2016;11:e0147701.
    PubMed     Text format     Abstract available
    
    
    
49. WU J, Cui W, Cai Q, Fei J, et al
    The NPC1L1 Polymorphism 1679C>G Is Associated with Gallstone Disease in Chinese Patients.
    PLoS One. 2016;11:e0147562.
    PubMed     Text format     Abstract available
    
    
    
50. LI J, Li T, Sun P, Yu Q, et al
    Covered versus Uncovered Self-Expandable Metal Stents for Managing Malignant Distal Biliary Obstruction: A Meta-Analysis.
    PLoS One. 2016;11:e0149066.
    PubMed     Text format     Abstract available
    
    
    
51. WANG CH, Wu CY, Yang JC, Lien WC, et al
    Long-Term Outcomes of Patients with Acute Cholecystitis after Successful Percutaneous Cholecystostomy Treatment and the Risk Factors for Recurrence: A Decade Experience at a Single Center.
    PLoS One. 2016;11:e0148017.
    PubMed     Text format     Abstract available
    
    
    
52. VERHAAG EM, Buist-Homan M, Koehorst M, Groen AK, et al
    Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.
    PLoS One. 2016;11:e0149782.
    PubMed     Text format     Abstract available
    
    
    
53. HWANG SM, Jeon TY, Yoo SY, Kim JH, et al
    Alagille Syndrome Candidates for Liver Transplantation: Differentiation from End-Stage Biliary Atresia Using Preoperative CT.
    PLoS One. 2016;11:e0149681.
    PubMed     Text format     Abstract available
    
    
    
54. MAUVAIS FX, Gonzales E, Davit-Spraul A, Jacquemin E, et al
    Cholestasis Reveals Severe Cortisol Deficiency in Neonatal Pituitary Stalk Interruption Syndrome.
    PLoS One. 2016;11:e0147750.
    PubMed     Text format     Abstract available
    
    
    
55. ROSE JB, Correa-Gallego C, Li Y, Nelson J, et al
    The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma.
    PLoS One. 2016;11:e0150195.
    PubMed     Text format     Abstract available
    
    
    
56. SIEGMUND SV, Schlosser M, Schildberg FA, Seki E, et al
    Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells.
    PLoS One. 2016;11:e0150893.
    PubMed     Text format     Abstract available
    
    
    
57. YE F, Shen H, Li Z, Meng F, et al
    Influence of the Biliary System on Biliary Bacteria Revealed by Bacterial Communities of the Human Biliary and Upper Digestive Tracts.
    PLoS One. 2016;11:e0150519.
    PubMed     Text format     Abstract available
    
    
    
58. COFER ZC, Cui S, EauClaire SF, Kim C, et al
    Methylation Microarray Studies Highlight PDGFA Expression as a Factor in Biliary Atresia.
    PLoS One. 2016;11:e0151521.
    PubMed     Text format     Abstract available
    
    
    
59. HA HR, Oh DY, Kim TY, Lee K, et al
    Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer.
    PLoS One. 2016;11:e0151406.
    PubMed     Text format     Abstract available
    
    
    
60. COSTANTINI R, Affaitati G, Massimini F, Tana C, et al
    Laparoscopic Cholecystectomy for Gallbladder Calculosis in Fibromyalgia Patients: Impact on Musculoskeletal Pain, Somatic Hyperalgesia and Central Sensitization.
    PLoS One. 2016;11:e0153408.
    PubMed     Text format     Abstract available
    
    
    
61. WANG NL, Li LT, Wu BB, Gong JY, et al
    The Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency.
    PLoS One. 2016;11:e0153114.
    PubMed     Text format     Abstract available
    
    
    
62. HUANG SG, Guo WL, Wang J, Sheng M, et al
    Factors Interfering with Delineation on MRCP of Pancreaticobiliary Maljunction in Paediatric Patients.
    PLoS One. 2016;11:e0154178.
    PubMed     Text format     Abstract available
    
    
    
63. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis.
    PLoS One. 2016;11:e0164224.
    PubMed     Text format     Abstract available
    
    
    
64. MANTEL HT, Westerkamp AC, Adam R, Bennet WF, et al
    Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival.
    PLoS One. 2016;11:e0156127.
    PubMed     Text format     Abstract available
    
    
    January 2015
65. MENG Y, Liang Y, Liu M
    The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis.
    PLoS One. 2015;10:e0120110.
    PubMed     Text format     Abstract available
    
    
    
66. LIM YP, Lin CL, Lin YN, Ma WC, et al
    Antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts.
    PLoS One. 2015;10:e0116960.
    PubMed     Text format     Abstract available
    
    
    
67. MISCHIATI C, Ura B, Roncoroni L, Elli L, et al
    Changes in protein expression in two cholangiocarcinoma cell lines undergoing formation of multicellular tumor spheroids in vitro.
    PLoS One. 2015;10:e0118906.
    PubMed     Text format     Abstract available
    
    
    
68. KOJIMA M, Sudo H, Kawauchi J, Takizawa S, et al
    MicroRNA Markers for the Diagnosis of Pancreatic and Biliary-Tract Cancers.
    PLoS One. 2015;10:e0118220.
    PubMed     Text format     Abstract available
    
    
    
69. MA F, Zhang M, Gong W, Weng M, et al
    MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma.
    PLoS One. 2015;10:e0126499.
    PubMed     Text format     Abstract available
    
    
    
70. SUN DX, Tan XD, Gao F, Xu J, et al
    Use of an autologous liver round ligament flap zeros postoperative bile leak after curative resection of hilar cholangiocarcinoma.
    PLoS One. 2015;10:e0125977.
    PubMed     Text format     Abstract available
    
    
    
71. LIU TY, Gong W, Tan ZJ, Lu W, et al
    Baicalein inhibits progression of gallbladder cancer cells by downregulating ZFX.
    PLoS One. 2015;10:e0114851.
    PubMed     Text format     Abstract available
    
    
    
72. NAKAMURA K, Nakabayashi K, Htet Aung K, Aizawa K, et al
    DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status.
    PLoS One. 2015;10:e0120545.
    PubMed     Text format     Abstract available
    
    
    
73. CHAI J, Feng X, Zhang L, Chen S, et al
    Hepatic expression of detoxification enzymes is decreased in human obstructive cholestasis due to gallstone biliary obstruction.
    PLoS One. 2015;10:e0120055.
    PubMed     Text format     Abstract available
    
    
    
74. CHANG CH, Chen YC, Zhang W, Leung PS, et al
    Innate immunity drives the initiation of a murine model of primary biliary cirrhosis.
    PLoS One. 2015;10:e0121320.
    PubMed     Text format     Abstract available
    
    
    
75. TSAI MC, Chen CH, Lee HC, Lin HC, et al
    Increased Risk of Depressive Disorder following Cholecystectomy for Gallstones.
    PLoS One. 2015;10:e0129962.
    PubMed     Text format     Abstract available
    
    
    
76. ALTEKRUSE SF, Petrick JL, Rolin AI, Cuccinelli JE, et al
    Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
    PLoS One. 2015;10:e0120574.
    PubMed     Text format     Abstract available
    
    
    
77. MORRIS S, Gurusamy KS, Sheringham J, Davidson BR, et al
    Cost-effectiveness analysis of endoscopic ultrasound versus magnetic resonance cholangiopancreatography in patients with suspected common bile duct stones.
    PLoS One. 2015;10:e0121699.
    PubMed     Text format     Abstract available
    
    
    
78. SEKIGUCHI T, Umemura T, Fujimori N, Shibata S, et al
    Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis.
    PLoS One. 2015;10:e0131658.
    PubMed     Text format     Abstract available
    
    
    
79. EHEHALT F, Sturm D, Rosler M, Distler M, et al
    Blood Glucose Homeostasis in the Course of Partial Pancreatectomy - Evidence for Surgically Reversible Diabetes Induced by Cholestasis.
    PLoS One. 2015;10:e0134140.
    PubMed     Text format     Abstract available
    
    
    
80. LIN KY, Liao SH, Liu WC, Cheng A, et al
    Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy.
    PLoS One. 2015;10:e0137660.
    PubMed     Text format     Abstract available
    
    
    
81. THEYSOHN JM, Ruhlmann M, Muller S, Dechene A, et al
    Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?
    PLoS One. 2015;10:e0137587.
    PubMed     Text format     Abstract available
    
    
    January 2014
82. BERGLIN L, Bergquist A, Johansson H, Glaumann H, et al
    In situ characterization of intrahepatic non-parenchymal cells in PSC reveals phenotypic patterns associated with disease severity.
    PLoS One. 2014;9:e105375.
    PubMed     Text format     Abstract available
    
    
    
83. KEANE MG, Horsfall LJ, Rait G, Pereira SP, et al
    Sociodemographic Trends in the Incidence of Pancreatic and Biliary Tract Cancer in UK Primary Care.
    PLoS One. 2014;9:e108498.
    PubMed     Text format     Abstract available
    
    
    
84. SAVERINO D, Pesce G, Antola P, Porcelli B, et al
    High levels of soluble ctla-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis.
    PLoS One. 2014;9:e112509.
    PubMed     Text format     Abstract available
    
    
    
85. TAN Y, Pan T, Ye Y, Ge G, et al
    Serum MicroRNAs as Potential Biomarkers of Primary Biliary Cirrhosis.
    PLoS One. 2014;9:e111424.
    PubMed     Text format     Abstract available
    
    
    
86. ZHANG YC, Qu EZ, Ren J, Zhang Q, et al
    New Diagnosis and Therapy Model for Ischemic-Type Biliary Lesions following Liver Transplantation-A Retrospective Cohort Study.
    PLoS One. 2014;9:e105795.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: